Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Predicting MRI Changes in Patients with MS in the Absence of Acute Inflammation

Author:Tur, Carmen   Sun, Zhaonan   Bradley, Daniel   Grossman, Cynthia   Montalban, Xavier   Rovira, Alex   Tintore, Mar   Campbell, Nolan   Fisher, Elizabeth   

Session Name:P11: MS Neuroimaging 2  

Topic:MS and Inflammatory Disease  

Program Number:P11.010  

Author Institution:Vall d'Hebron, Barcelona, Spain  Biogen Inc., Cambridge, MA  

Comparison of Therapeutic Efficacy of Gene Therapy for Tuberous Sclerosis Type 2 with Standard of Care Everolimus in Preclinical Model

Author:Abou Haidar, Edwina   Prabhakar, Shilpa   Cheah, Pike See   Lule, Sevda   Beauchamp, Roberta L.   Yoshinaga, Akiko   Geffrey, Alexandra L.   Stemmer-Rachamimov, Anat   Ramesh, Vijaya   Maguire, Casey A.   Breakefield, Xandra O.   

Session Name:S14: General Neurology: Emerging Therapies  

Topic:General Neurology  

Program Number:S14.002  

Author Institution:Massachusetts General Hospital, Boston, MA  Massachusetts General Hospital, Charlestown, MA  

Acetyl-L-Leucine for Niemann-Pick type C: A Multinational Double-blind Randomized Placebo-controlled Crossover Study

Author:Bremova-Ertl, Tatiana   Fields, Taylor   Martakis, Kyriakos   Strupp, Michael   

Session Name:P14: Movement Disorders: Miscellaneous Movement Disorders 2  

Topic:Movement Disorders  

Program Number:P14.001  

Author Institution:University Hospital Inselspital Bern, Bern, Switzerland  Intrabio, Ltd., London, United Kingdom  University Hospital Giessen, Giessen, Germany  LMU University Hospital Munich, Munich, Germany  

A Patient Registry to Identify Barriers to Health Care in an Underserved Parkinson’s Disease Population

Author:Bissonnette, Stephanie   Owen, Rosemary   Martin, Ashley   Bird, Katelyn   Stevenson, Michael   James, Ray   Lee, Rebekah   Desrosier, Abigail   Ellis, Theresa   Wendel, Nicholas   Bresler, Helen   Lee, Bertha   Thomas, Cathi Ann   Saint-Hilaire, Marie-Helene   Shih, Ludy   

Session Name:P4: Health Care Disparities: Dementia, Movement, Neuromuscular, MS  

Topic:Health Care Disparities  

Program Number:P4.004  

Author Institution:Boston University School of Medicine, Roxbury, MA  Boston Medical Center, Boston, MA  Boston University Sargent College of Rehabilitation, Boston, MA  Massachusetts College of Pharmacy and Health Sciences, Boston, MA  

Long-Term Safety, Tolerability, And Efficacy of Efgartigimod in Patients with Generalized Myasthenia Gravis: Concluding Analyses from the ADAPT+ Study

Author:Pasnoor, Mamatha   Bril, Vera   Karam, Chafic   Peric, Stojan   De Bleecker, Jan   Murai, Hiroyuki   Meisel, Andreas   Beydoun, Said   Vu, Tuan   Ulrichts, Peter   Van Hoorick, Benjamin   T'joen, Caroline   Utsugisawa, Kimiaki   Verschuuren, Jan   Mantegazza, Renato   Howard, James   ADAPT Investigator Study Group, in collaboration with the   

Session Name:S5: Autoimmune Neurology: NMOSD and MG, A Focus on Treatment Trials  

Topic:Autoimmune Neurology  

Program Number:S5.006  

Author Institution:University of Kansas Medical Center, Kansas City, KS  Ellen & Martin Prosserman Centre for Neuromuscular Diseases, University Health Network, Toronto, ON, Canada  Penn Neuroscience Center, University of Pennsylvania, Philadelphia, PA  Clinical Center of Serbia, University of Belgrade, Belgrade, Serbia  Ghent University Hospital, Gent, Belgium  School of Medicine, International University of Health and Welfare, Narita, Japan  Charité – Universitätsmedizin Berlin, Berlin, Germany  Keck School of Medicine, University of Southern California, Los Angeles, CA  University of South Florida, Morsani College of Medicine, Tampa, FL  argenx, Ghent, Belgium  Hanamaki General Hospital, Hanamaki, Japan  Leiden University Medical Center, Leiden, Netherlands  Fondazione Istituto Neurologico Carlo Besta, Milan, Italy  The University of North Carolina, Chapel Hill, NC  N/A, Yardley, PA